NCT01652313View on ClinicalTrials.gov

Pharmacokinetic Properties of Rasagiline (Lu 00-773) in Healthy Young Chinese Men and Women

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2012

Conditions
Parkinson's Disease
Interventions
DRUG

Rasagiline

1 mg/day, tablets for 7 days, orally

Trial Locations (1)

Unknown

CN001, Beijing

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT01652313 - Pharmacokinetic Properties of Rasagiline (Lu 00-773) in Healthy Young Chinese Men and Women | Biotech Hunter | Biotech Hunter